186 related articles for article (PubMed ID: 30006925)
1. Statin therapy and association with ovarian cancer risk in the New England Case Control (NEC) study.
Akinwunmi B; Vitonis AF; Titus L; Terry KL; Cramer DW
Int J Cancer; 2019 Mar; 144(5):991-1000. PubMed ID: 30006925
[TBL] [Abstract][Full Text] [Related]
2. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
3. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
Vogel TJ; Goodman MT; Li AJ; Jeon CY
Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
[TBL] [Abstract][Full Text] [Related]
4. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Läärä E; Hinkula M
BJOG; 2018 Jul; 125(8):1001-1008. PubMed ID: 29412502
[TBL] [Abstract][Full Text] [Related]
5. Statin use and risk for ovarian cancer: a Danish nationwide case-control study.
Baandrup L; Dehlendorff C; Friis S; Olsen JH; Kjær SK
Br J Cancer; 2015 Jan; 112(1):157-61. PubMed ID: 25393364
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of studies assessing the relationship between statin use and risk of ovarian cancer.
Irvin S; Clarke MA; Trabert B; Wentzensen N
Cancer Causes Control; 2020 Oct; 31(10):869-879. PubMed ID: 32685996
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative.
Desai P; Wallace R; Anderson ML; Howard BV; Ray RM; Wu C; Safford M; Martin LW; Rohan T; Manson JE; Simon MS
Gynecol Oncol; 2018 Mar; 148(3):540-546. PubMed ID: 29422345
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
[TBL] [Abstract][Full Text] [Related]
9. Associations between statin use and risk of non-Hodgkin lymphomas by subtype.
Ye X; Zhang G; Righolt C; Johnston JB; Banerji V; Gibson SB; Mahmud SM
Int J Cancer; 2018 Aug; 143(4):971-979. PubMed ID: 29524215
[TBL] [Abstract][Full Text] [Related]
10. Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study.
Borahay MA; Fang X; Baillargeon JG; Kilic GS; Boehning DF; Kuo YF
Am J Obstet Gynecol; 2016 Dec; 215(6):750.e1-750.e8. PubMed ID: 27371355
[TBL] [Abstract][Full Text] [Related]
11. Statin use and mortality among ovarian cancer patients: A population-based cohort study.
Verdoodt F; Kjaer Hansen M; Kjaer SK; Pottegård A; Friis S; Dehlendorff C
Int J Cancer; 2017 Jul; 141(2):279-286. PubMed ID: 28411390
[TBL] [Abstract][Full Text] [Related]
12. The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.
Cramer DW; Vitonis AF; Terry KL; Welch WR; Titus LJ
Epidemiology; 2016 May; 27(3):334-46. PubMed ID: 26689397
[TBL] [Abstract][Full Text] [Related]
13. Impact of statin therapy on survival in epithelial ovarian cancer.
Elmore RG; Ioffe Y; Scoles DR; Karlan BY; Li AJ
Gynecol Oncol; 2008 Oct; 111(1):102-5. PubMed ID: 20698078
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydrophilic and lipophilic statins on early onset cataract: A nationwide case-control study.
Chen HL; Chang HM; Wu HJ; Lin YC; Chang YH; Chang YC; Lee WH; Chang CT
Regul Toxicol Pharmacol; 2021 Aug; 124():104970. PubMed ID: 34087384
[TBL] [Abstract][Full Text] [Related]
15. Hip fracture risk in statin users--a population-based Danish case-control study.
Rejnmark L; Olsen ML; Johnsen SP; Vestergaard P; Sørensen HT; Mosekilde L
Osteoporos Int; 2004 Jun; 15(6):452-8. PubMed ID: 15205716
[TBL] [Abstract][Full Text] [Related]
16. Statin use and risk of glioma: population-based case-control analysis.
Seliger C; Meier CR; Becker C; Jick SS; Bogdahn U; Hau P; Leitzmann MF
Eur J Epidemiol; 2016 Sep; 31(9):947-52. PubMed ID: 27041698
[TBL] [Abstract][Full Text] [Related]
17. The differential effects of statins on the risk of developing pancreatic cancer: a case-control study in two centres in the United Kingdom.
Carey FJ; Little MW; Pugh TF; Ndokera R; Ing H; Clark A; Dennison A; Metcalfe MS; Robinson RJ; Hart AR
Dig Dis Sci; 2013 Nov; 58(11):3308-12. PubMed ID: 23864194
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Am J Epidemiol; 2002 Aug; 156(4):363-73. PubMed ID: 12181107
[TBL] [Abstract][Full Text] [Related]
19. Lipophilic statin use and risk of breast cancer subtypes.
Woditschka S; Habel LA; Udaltsova N; Friedman GD; Sieh W
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2479-87. PubMed ID: 20729289
[TBL] [Abstract][Full Text] [Related]
20. Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study.
Majidi A; Na R; Jordan SJ; De Fazio A; Webb PM;
Int J Cancer; 2021 Apr; 148(7):1608-1615. PubMed ID: 33034053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
